Bellevue Life Sciences Acquisition's minority interest is $24M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), BLAC shows a minority interest of $24M. That compares with $57M in the prior-year period — down 58.4% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, BLAC's minority interest is now $24M (was $57M) — a 58.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bellevue Life Sciences Acquisition is outperforming or lagging.
Tracking BLAC's minority interest over time shows whether Bellevue Life Sciences Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $24M That compares with $57M in the prior-year period — down 58.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this minority interest page, Stockcircle has Bellevue Life Sciences Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $24M) with ownership activity and broader fundamentals.